ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.32
-0.65%
US Tech 100
18,597.60
0.34%
S&P 500
5,366.36
0.25%
US Dollar vs CAD
1.37515
0.60%
Bitcoin
70,740.08
-0.03%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Theravance Biopharma Inc (TBPH)

  7. Theravance Biopharma Inc (TBPH) News

TBPH Theravance Biopharma Inc

8.785
-0.095 (-1.07%)
Last Updated: 11:52:04
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Theravance Biopharma Inc TBPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.095 -1.07% 8.785 11:52:04
Open Price Low Price High Price Close Price Previous Close
8.78 8.7528 8.87 8.88
more quote information »

Recent News

Date Time Source Heading
5/22/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/22/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/22/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/22/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/15/202405:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202415:13EDGAR2Form 8-K - Current report
5/13/202415:05PRNUSTheravance Biopharma, Inc. Reports First Quarter 2024..
5/10/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:15EDGAR2Form 8-K - Current report
5/09/202405:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
4/29/202405:00PRNUSTheravance Biopharma to Report First Quarter 2024 Financial..
4/10/202405:00PRNUSTheravance Biopharma, Inc. to Host Virtual Key Opinion..
2/26/202415:16EDGAR2Form 8-K - Current report
2/26/202415:05PRNUSTheravance Biopharma, Inc. Reports Fourth Quarter and Full..
2/22/202419:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202405:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
2/16/202419:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/14/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202405:00PRNUSTheravance Biopharma to Report Fourth Quarter and Full Year..
1/16/202405:16EDGAR2Form 8-K - Current report
1/05/202405:07EDGAR2Form 8-K - Current report
1/05/202405:00PRNUSTheravance Biopharma Announces Results from the Phase 4..
12/28/202305:01EDGAR2Form 8-K - Current report
12/26/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202317:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/21/202316:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/21/202316:06EDGAR2Form 8-K - Current report
12/21/202316:00PRNUSTheravance Biopharma, Inc. Announces Appointment of Jeremy..
12/18/202305:00PRNUSTheravance Biopharma to Conduct Investor Meetings During the..
11/22/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202305:00PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
11/15/202305:00PRNUSTheravance Biopharma to Participate in the 6th Annual..
11/13/202307:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
11/09/202315:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:53EDGAR2Form 8-K - Current report
11/07/202315:28PRNUSTheravance Biopharma, Inc. Reports Third Quarter 2023..
11/01/202317:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202316:15EDGAR2Form 8-K - Current report
10/19/202305:00PRNUSTheravance Biopharma to Report Third Quarter 2023 Financial..

Your Recent History

NASDAQ
TBPH
Theravance Biopharma
LSE
SRSA
Ishr Msci
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved